AI software which helps diagnose lung cancer receives gov funding boost

Post author:Rhiannon Lassiter
Post published:July 5, 2021
Post category:Media

An article has appeared Digital Health about Optellum’s recent grant success.

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA
J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
J&J teams up with Optellum to improve lung cancer survival rates
Optellum collaborating with J&J
Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. Our vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back.

You Might Also Like

Digital Health Roundup (subscription required)

OPTELLUM TO COLLABORATE WITH JOHNSON & JOHNSON ON APPLYING AI TO TRANSFORM EARLY LUNG CANCER TREATMENT

Oxford spin out partners with J&J to transform lung cancer treatment